The cardiovascular risk associated with impaired glucose tolerance

Diabetic Medicine

Volumn 13, Issue 3 SUPPL. 2, 1996, Pages

  Jarrett, R J ^a  

^a NONE   (United Kingdom)

Author keywords

Cardiovascular disease; Impaired glucose tolerance

Indexed keywords

CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERGLYCEMIA; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SEX CHARACTERISTICS;

EID: 0029940738     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Stamler R, Stamler J, eds. Asymptomatic hyperglycemia and coronary heart disease: a series of papers by the international collaborative group, based upon studies in fifteen populations. J Chron Dis 1979; 32: 683-837.
2. Eschwège E, Richard JL, Thibult N, Ducimetière P, Warnet JM, Claude JR, Rosselin GE. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels: the Paris Prospective Study, ten years later. Horm Metabol Res 1985; Suppl 15: 41-46.
3. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979; 2: 131-141.
4. Fuller JH, Shipley M, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall Study. BMJ 1983; 287: 867-870.
5. Pan W-H, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, Stamler R, Smith D, Collette P, Stamler JH. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 1986; 123: 504-516.
6. Janghorbani M, Jones RB, Gilmour WH, Hedley AJ, Zhanpour M. A prospective population study of gender differential in mortality from cardiovascular disease and 'all-causes' in asymptomatic hyperglycaemics. J Clin Epidemiol 1994; 47: 397-405.
7. Perry IJ, Wannamethee G, Whincup PH, Shaper AG. Asymptomatic hyperglycaemia and major ischaemic heart disease events in Britain. J Epidemiol Comm Health 1994; 48: 538-542.
8. Yarnell JWG, Pickering JE, Elwood PC, Baker IA, Bainton D, Dawkins C, Phillips DIW. Does non-diabetic hyperglycaemia predict future IHD? Evidence from the Caerphilly and Speedwell studies. J Clin Epidemiol 1994; 47: 383-388.
9. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1038-1057.
10. WHO Expert Committee on Diabetes Mellitus. Second Report. Tech Rep Ser 646. Geneva: WHO, 1980.
11. Ohlson L-O, Bjuro T, Larsson B, Eriksson H, Svardsudd K, Welin L, Wilhelmsen L. A cross-sectional analysis of glucose tolerance and cardiovascular disease in 67-year-old men. Diabetic Med 1989; 6: 112-120.
12. Pan X-R, Liu P-A, Hu Y-H, Bennett PH, Li G-W, Howard BV. Impaired glucose tolerance and its relationship to ECG-indicated coronary heart disease and risk factors among Chinese: Da Qing IGT and diabetes study. Diabetes Care 1993; 16: 150-156.
13. Rewers M, Shetterly SM, Baxter J, Marshall JA, Hamman RF. Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a biethnic Colorado population: the San Luis Valley Study. Am J Epidemiol 1992; 135: 1321-1330.
14. Fontbonne A, Eschwège E, Cambien F, Richard J-L, Ducimetière P, Thibult N, Warnet J-M, Claude J-R, Rosselin G-E. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 1989; 32: 300-304.
15. Jarrett RJ, Fitzgerald AP. Height and glucose tolerance (letter). Diabetologia 1992; 35: 191-192.
16. Stengard JH, Tuomilehto J, Pekkanen J, Kivinen P, Kaarsalo E, Nissinen A, Karvonen MJ, Diabetes mellitus, impaired glucose tolerance and mortality among elderly men: the Finnish cohorts of the Seven Countries Study. Diabetologia 1992; 35: 760-765.
17. Kuusisto J, Mykkanen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994; 43: 960-967.
18. The University Group Diabetes Program. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment. JAMA 1978; 240: 37-42.
19. United Kingdom Prospective Diabetes Study. VIII. Study design, progress and performance. Diabetologia 1991; 34: 877-890.
20. McPhillips JB, Barrett-Connor E, Wingard DL. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol 1990; 131: 443-453.
21. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990; 263: 2893-2898.
22. Jarrett RJ. Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease - chicken, egg or neither? Diabetologia 1984; 26: 99-102.
23. Vaccaro O, Rivellese A, Riccardi G, Capaldo B, Tutino L, Annuzzi G, Mancini M. Impaired glucose tolerance and risk factors for atherosclerosis. Arteriosclerosis 1984; 4: 592-597.
24. Yamada N, Gotoda T, Yoshinaga H, Ohashi Y, Sakurai N, Yazaki Y, Shimano H, Kosaka K. Increased risk factors for coronary heart disease in Japanese subjects with hyperinsulinemia or glucose intolerance. Diabetes Care 1994; 17: 107-114.
25. Fujimoto WY, Bergstrom RW, Leonetti DL, Newell-Morris LL, Shuman WP, Wahl PW. Metabolic and adipose risk factors for NIDDM and coronary disease in third-generation Japanese-American men and women with impaired glucose tolerance. Diabetologia 1994; 37: 524-532.